Literature DB >> 11039295

[Metaphyseal defect substitute: hydroxylapatite ceramic. Results of a 3 to 4 year follow up].

M U Helber1, C Ulrich.   

Abstract

45 trauma patients with fracture-related metaphyseal bone defects filled with hydroxyapatite ceramic (Endobon) were followed for three to four years after surgery. Osseointegration of Endobon could be confirmed histologically in all biopsates, which could be obtained during scheduled reintervention for hardware removal. The objective of clinical and radiological follow-up was to evaluate the extent of ceramic remodeling as well as long-term implant outcome. Thirteen patients undergoing surgery in 1992 or 1993 were available for follow-up. None of these patients showed radiologic evidence of loss of bony reconstruction or HAC sintering, nor was there evidence of HAC resorption or fragmentation. Our results--with respect to the examined few patients--suggest that Endobon is useful for filling bony defects in carefully selected trauma patients if certain surgical technique prerequisites are met. Like cancellous autografts special alloplasts appear to go some way toward solving problems of defect filling encountered in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11039295     DOI: 10.1007/s001130050614

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  4 in total

1.  Major bone defect treatment with an osteoconductive bone substitute.

Authors:  Stefania Paderni; S Terzi; L Amendola
Journal:  Chir Organi Mov       Date:  2009-06-16

2.  Evaluation of a novel nanocrystalline hydroxyapatite paste and a solid hydroxyapatite ceramic for the treatment of critical size bone defects (CSD) in rabbits.

Authors:  Franz-Xaver Huber; Irina Berger; Nicholas McArthur; Colette Huber; Hans-Peter Kock; Jürgen Hillmeier; Peter Jürgen Meeder
Journal:  J Mater Sci Mater Med       Date:  2007-06-14       Impact factor: 3.896

3.  [Mechanical failure of porous hydroxyapatite ceramics 7.5 years after implantation in the proximal tibial].

Authors:  W Linhart; D Briem; M Amling; J M Rueger; J Windolf
Journal:  Unfallchirurg       Date:  2004-02       Impact factor: 1.000

4.  Hydroxyapatite crystals as a bone graft substitute in benign lytic lesions of bone.

Authors:  Anil Kumar Gupta; Praganesh Kumar; Kumar Keshav; Anant Singh
Journal:  Indian J Orthop       Date:  2015 Nov-Dec       Impact factor: 1.251

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.